Outbreak of extended-spectrum β-lactamase-producing Klebsiella oxytoca infections associated with contaminated handwashing sinks

Emerging Infectious Diseases

Volumn 18, Issue 8, 2012, Pages 1242-1247

  Lowe, Christopher ^a   Willey, Barbara ^b   O'Shaughnessy, Anna ^b   Lee, Wayne ^b   Lum, Ming ^b   Pike, Karen ^b   Larocque, Cindy ^b   Dedier, Helen ^b   Dales, Lorraine ^b   Moore, Christine ^b   McGeer, Allison ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANADA; EPIDEMIC; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA INFECTION; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY;

BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; EQUIPMENT CONTAMINATION; HAND DISINFECTION; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; ONTARIO; WATER SUPPLY;

EID: 84864455923     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1808.111268     Document Type: Article

References (22)

1. Decré D, Burghoffer B, Gautier B, Petit JC, Arlet G. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extendedspectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase. J Antimicrob Chemother. 2004;54:881-8. http://dx.doi.org/10.1093/jac/dkh440
2. Jeong SH, Kim WM, Chang CL, Kim JM, Lee K, Chong Y, et al. Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal β -lactamase. J Hosp Infect. 2001;48:281-8. http://dx.doi.org/10.1053/jhin.2001.1018
3. Schulz-Stübner S, Kniehl E. Transmission of extended-spectrum β-lactamase Klebsiella oxytoca via the breathing circuit of a transport ventilator: root cause analysis and infection control recommendations. Infect Control Hosp Epidemiol. 2011;32:828-9. http://dx.doi.org/10.1086/661225
4. Zárate MS, Gales AC, Picão RC, Pujol GS, Lanza A, Smayevsky J. Outbreak of OXY-2-producing Klebsiella oxytoca in a renal transplant unit. J Clin Microbiol. 2008;46:2099-101. http://dx.doi.org/10.1128/JCM.00194-08
5. Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. First report of Klebsiella oxytoca strain coproducing KPC-2 and IMP-8 carbapenemases. Antimicrob Agents Chemother. 2011;55:2937-41. http://dx.doi.org/10.1128/AAC.01670-10
6. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. http://dx.doi.org/10.1016/j.ajic.2008.03.002
7. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S16. Wayne (PA): The Institute; 2010.
8. Katsios CM, Burry L, Khory T, Howie S, Wax R, Bell C, et al. An antimicrobial stewardship program improves the quality of antimicrobial prescribing in an ICU. In: Critical Care Canada Forum 2010; Toronto, Ontario, Canada; 2010 Nov 7-10 [cited 2012 Mar 22]. http://www.criticalcarecanada.com/abstracts/2010/an-antimicrobialstewardship-program-improves-the-quality-of-antimicrobial_prescribing_in_an_icu.aspx
9. Reiss I, Borkhardt A, Füssle R, Sziegoleit A, Gortner L. Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies. Lancet. 2000;356:310. http://dx.doi.org/10.1016/S01406736(00)02509-5
10. Watson JT, Jones RC, Siston AM, Fernandez JR, Martin K, Beck E, et al. Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center. Arch Intern Med. 2005;165:2639-43. http://dx.doi.org/10.1001/archinte.165.22.2639
11. Sardan YC, Zarakolu P, Altun B, Yildirim A, Yildirim G, Hascelik G, et al. A cluster of nosocomial Klebsiella oxytoca bloodstream infections in a university hospital. Infect Control Hosp Epidemiol. 2004;25:878-82. http://dx.doi.org/10.1086/502313
12. Laurent C, Rodriguez-Villalobos H, Rost F, Strale H, Vincent JL, Deplano A, et al. Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol. 2008;29:517-24. http://dx.doi.org/10.1086/588004
13. Calbo E, Freixas N, Xercavins M, Riera M, Nicolas C, Monistrol O, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis. 2011;52:743-9. http://dx.doi.org/10.1093/cid/ciq238
14. Kola A, Holst M, Chaberny IF, Ziesing S, Suerbaum S, Gastmeier P. Surveillance of extended-spectrum β-lactamase producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect. 2007;66:46-51. http://dx.doi.org/10.1016/j.jhin.2007.01.006
15. O'Fallon E, Gautam S, D'Agata EMC. Colonization with multidrugresistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis. 2009;48:1375-81. http://dx.doi.org/10.1086/598194
16. Weintrob AC, Roediger MP, Barber M, Summers A, Fieberg AM, Dunn J, et al. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol. 2010;31:330-7. http://dx.doi.org/10.1086/651304
17. Tsakris A, Poulou A, Markou F, Pitiriga V, Piperaki ET, Kristo I, et al. Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a new OXY-2-type variant in the community. Antimicrob Agents Chemother. 2011;55:3164-8. http://dx.doi.org/10.1128/AAC.00102-11
18. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007;45:846-52. http://dx.doi.org/10.1086/521260
19. Cuttelod M, Senn L, Terletskiy V, Nahimana I, Petignat C, Eggimann P, et al. Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10-year period (1998-2007). Clin Microbiol Infect. 2011;17:57-62. http://dx.doi.org/10.1111/j.14690691.2010.03164.x
20. Hota S, Hirji Z, Stockton K, Lemieux C, Dedier H, Wolfaardt G, et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol. 2009;30:25-33. http://dx.doi.org/10.1086/592700
21. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002;8:881-90. http://dx.doi.org/10.3201/eid0809.020063
22. Tang X, Flint SH, Bennett RJ, Brooks JD, Morton RH. Biofilm growth of individual and dual strains of Klebsiella oxytoca from the dairy industry on ultrafiltration membranes. J Ind Microbiol Biotechnol. 2009;36:1491-7. http://dx.doi.org/10.1007/s10295-009-0637-5